Global CAR T-Cell Therapy Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major 40 Countries or Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • The CAR T-Cell Therapy is expected to grow from USD XX.0 million in 2018 to USD XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of XX.0% during the forecast period. The research provides insights for the global CAR T-Cell Therapy market based on different Types, End-Users and Regions, and competitive landscape of these segments are analyzed in detail.

    A wide range of market influence factors are taken into consideration in the analysis, and potential developing factors for different Types, End-Users and Regions are also included in the report in order to figure out the most promising development trends in the CAR T-Cell Therapy industry. For presenting the most potential investment fields in North America, Europe, Asia Pacific and Latin America, Middle East & Africa, the market capacity and consumption potential of more than 34 major powers are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Global CAR T-Cell Therapy Market Segmentations:

    By Players:

    • Autolus Therapeutics PLC (UK)

    • Juno Therapeutics (US)

    • Cellectis (France)

    • Kite Pharma (US)

    • CARsgen Therapeutics (China)

    • Novartis AG (Switzerland)

    • Pfizer, Inc (US)

    • Sorrento Therapeutics (US)

    • Mustang Bio (US)

    • Legend Biotech (US)

    By Types:

    • Allogeneic

    • Autologous

    By End-User:

    • Hospitals

    • Cancer Research Centers

    • Others

    By Regions:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • France

    • Italy

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

    • Spain

    • Belgium

    • Poland

    • Russia

    • Turkey

    • Others

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Australia and New Zealand

    • ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)

    Latin America, Middle East & Africa

    • GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)

    • Brazil

    • Nigeria

    • South Africa

    • Argentina

    • Others

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of CAR T-Cell Therapy Market

    • 1.3 Market Segmentation by Type

      • 1.3.1 Global CAR T-Cell Therapy Market Size and Growth Rate of Allogeneic from 2014 to 2026

      • 1.3.2 Global CAR T-Cell Therapy Market Size and Growth Rate of Autologous from 2014 to 2026

    • 1.4 Market Segmentation by End-Users

      • 1.4.1 Global CAR T-Cell Therapy Market Size and Growth Rate of Hospitals from 2014 to 2026

      • 1.4.2 Global CAR T-Cell Therapy Market Size and Growth Rate of Cancer Research Centers from 2014 to 2026

      • 1.4.3 Global CAR T-Cell Therapy Market Size and Growth Rate of Others from 2014 to 2026

    • 1.5 Market Segmentation by Regions

      • 1.5.1 North America CAR T-Cell Therapy Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.1 United States CAR T-Cell Therapy Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.2 Canada CAR T-Cell Therapy Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.3 Mexico CAR T-Cell Therapy Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Europe CAR T-Cell Therapy Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.1 Germany CAR T-Cell Therapy Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.2 UK CAR T-Cell Therapy Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.3 France CAR T-Cell Therapy Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.4 Italy CAR T-Cell Therapy Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.5 Nordic Countries CAR T-Cell Therapy Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.6 Spain CAR T-Cell Therapy Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.7 Belgium CAR T-Cell Therapy Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.8 Poland CAR T-Cell Therapy Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.9 Russia CAR T-Cell Therapy Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.10 Turkey CAR T-Cell Therapy Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Asia-Pacific CAR T-Cell Therapy Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.1 China CAR T-Cell Therapy Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.2 Japan CAR T-Cell Therapy Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.3 Australia and New Zealand CAR T-Cell Therapy Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.4 India CAR T-Cell Therapy Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.5 ASEAN Countries CAR T-Cell Therapy Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.6 South Korea CAR T-Cell Therapy Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Latin America, Middle East & Africa CAR T-Cell Therapy Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.1 GCC Countries CAR T-Cell Therapy Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.2 Brazil CAR T-Cell Therapy Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.3 Nigeria CAR T-Cell Therapy Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.4 South Africa CAR T-Cell Therapy Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.5 Argentina CAR T-Cell Therapy Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints 

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of CAR T-Cell Therapy Market by Types

    • 3.1 Product Development Trends of Different Types

    • 3.2 Commercial Product Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of CAR T-Cell Therapy by Major Types

      • 3.4.1 CAR T-Cell Therapy Market Size and Growth Rate of Allogeneic

      • 3.4.2 CAR T-Cell Therapy Market Size and Growth Rate of Autologous

    4 Segmentation of CAR T-Cell Therapy Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of CAR T-Cell Therapy by Major End-Users

      • 4.4.1 Market Size and Growth Rate of CAR T-Cell Therapy in Hospitals

      • 4.4.2 Market Size and Growth Rate of CAR T-Cell Therapy in Cancer Research Centers

      • 4.4.3 Market Size and Growth Rate of CAR T-Cell Therapy in Others

    5 Market Analysis by Major Regions

    • 5.1 Global CAR T-Cell Therapy Production Analysis by Major Regions

    • 5.2 Global CAR T-Cell Therapy Consumption Analysis by Major Regions

    • 5.3 Global CAR T-Cell Therapy Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 North America CAR T-Cell Therapy Production, Import, Consumption and Export Analysis 

      • 5.3.2 Europe CAR T-Cell Therapy Production, Import, Consumption and Export Analysis

      • 5.3.3 Asia Pacific CAR T-Cell Therapy Production, Import, Consumption and Export Analysis

      • 5.3.4 Latin America, Middle East & Africa CAR T-Cell Therapy Production, Import, Consumption and Export Analysis

    6 Product Commodity of CAR T-Cell Therapy Market in Major Countries

    • 6.1 Top 5 Export Countries in CAR T-Cell Therapy market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries' Export Value Analysis in CAR T-Cell Therapy market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries'  Export Volume Analysis in CAR T-Cell Therapy market from 2014 to 2019

    • 6.2 Top 5 Import Countries in CAR T-Cell Therapy market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries' Import Value Analysis in CAR T-Cell Therapy market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries' Import Volume Analysis in CAR T-Cell Therapy market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7 North America CAR T-Cell Therapy Landscape Analysis

    • 7.1 North America CAR T-Cell Therapy Landscape Analysis by Major Types

    • 7.2 North America CAR T-Cell Therapy Landscape Analysis by Major End-Users

    • 7.3 North America CAR T-Cell Therapy Landscape Analysis by Major Countries

      • 7.3.1 United States CAR T-Cell Therapy Market Volume and Growth Rate

      • 7.3.2 Canada CAR T-Cell Therapy Market Volume and Growth Rate

      • 7.3.3 Mexico CAR T-Cell Therapy Market Volume and Growth Rate

    8 Europe CAR T-Cell Therapy Landscape Analysis

    • 8.1 Europe CAR T-Cell Therapy Landscape Analysis by Major Types

    • 8.2 Europe CAR T-Cell Therapy Landscape Analysis by Major End-Users

    • 8.3 Europe CAR T-Cell Therapy Landscape Analysis by Major Countries

      • 8.3.1 Germany CAR T-Cell Therapy Market Volume and Growth Rate

      • 8.3.2 UK CAR T-Cell Therapy Market Volume and Growth Rate

      • 8.3.3 France CAR T-Cell Therapy Market Volume and Growth Rate

      • 8.3.4 Italy CAR T-Cell Therapy Market Volume and Growth Rate

      • 8.3.5 Nordic Countries CAR T-Cell Therapy Market Volume and Growth Rate

      • 8.3.6 Spain CAR T-Cell Therapy Market Volume and Growth Rate

      • 8.3.7 Belgium CAR T-Cell Therapy Market Volume and Growth Rate

      • 8.3.8 Poland CAR T-Cell Therapy Market Volume and Growth Rate

      • 8.3.9 Russia CAR T-Cell Therapy Market Volume and Growth Rate

      • 8.3.10 Turkey CAR T-Cell Therapy Market Volume and Growth Rate

    9 Asia Pacific CAR T-Cell Therapy Landscape Analysis

    • 9.1 Asia Pacific CAR T-Cell Therapy Landscape Analysis by Major Types

    • 9.2 Asia Pacific CAR T-Cell Therapy Landscape Analysis by Major End-Users

    • 9.3 Asia Pacific CAR T-Cell Therapy Landscape Analysis by Major Countries

      • 9.3.1 China CAR T-Cell Therapy Market Volume and Growth Rate

      • 9.3.2 Japan CAR T-Cell Therapy Market Volume and Growth Rate

      • 9.3.3 Australia and New Zealand CAR T-Cell Therapy Market Volume and Growth Rate

      • 9.3.4 India CAR T-Cell Therapy Market Volume and Growth Rate

      • 9.3.5 ASEAN Countries CAR T-Cell Therapy Market Volume and Growth Rate

      • 9.3.6 South Korea CAR T-Cell Therapy Market Volume and Growth Rate

    10 Latin America, Middle East & Africa CAR T-Cell Therapy Landscape Analysis

    • 10.1 Latin America, Middle East & Africa CAR T-Cell Therapy Landscape Analysis by Major Types

    • 10.2 Latin America, Middle East & Africa CAR T-Cell Therapy Landscape Analysis by Major End-Users

    • 10.3 Latin America, Middle East & Africa CAR T-Cell Therapy Landscape Analysis by Major Countries

      • 10.3.1 GCC Countries CAR T-Cell Therapy Market Volume and Growth Rate

      • 10.3.2 Brazil CAR T-Cell Therapy Market Volume and Growth Rate

      • 10.3.3 Nigeria CAR T-Cell Therapy Market Volume and Growth Rate

      • 10.3.4 South Africa CAR T-Cell Therapy Market Volume and Growth Rate 

      • 10.3.5 Argentina CAR T-Cell Therapy Market Volume and Growth Rate

    11 Major Players Profile

    • 11.1 Autolus Therapeutics PLC (UK)

      • 11.1.1 Autolus Therapeutics PLC (UK) Company Profile and Recent Development

      • 11.1.2 Market Performance

      • 11.1.3 Product and Service Introduction

    • 11.2 Juno Therapeutics (US)

      • 11.2.1 Juno Therapeutics (US) Company Profile and Recent Development

      • 11.2.2 Market Performance

      • 11.2.3 Product and Service Introduction

    • 11.3 Cellectis (France)

      • 11.3.1 Cellectis (France) Company Profile and Recent Development

      • 11.3.2 Market Performance

      • 11.3.3 Product and Service Introduction

    • 11.4 Kite Pharma (US)

      • 11.4.1 Kite Pharma (US) Company Profile and Recent Development

      • 11.4.2 Market Performance

      • 11.4.3 Product and Service Introduction

    • 11.5 CARsgen Therapeutics (China)

      • 11.5.1 CARsgen Therapeutics (China) Company Profile and Recent Development

      • 11.5.2 Market Performance

      • 11.5.3 Product and Service Introduction

    • 11.6 Novartis AG (Switzerland)

      • 11.6.1 Novartis AG (Switzerland) Company Profile and Recent Development

      • 11.6.2 Market Performance

      • 11.6.3 Product and Service Introduction

    • 11.7 Pfizer, Inc (US)

      • 11.7.1 Pfizer, Inc (US) Company Profile and Recent Development

      • 11.7.2 Market Performance

      • 11.7.3 Product and Service Introduction

    • 11.8 Sorrento Therapeutics (US)

      • 11.8.1 Sorrento Therapeutics (US) Company Profile and Recent Development

      • 11.8.2 Market Performance

      • 11.8.3 Product and Service Introduction

    • 11.9 Mustang Bio (US)

      • 11.9.1 Mustang Bio (US) Company Profile and Recent Development

      • 11.9.2 Market Performance

      • 11.9.3 Product and Service Introduction

    • 11.10 Legend Biotech (US)

      • 11.10.1 Legend Biotech (US) Company Profile and Recent Development

      • 11.10.2 Market Performance

      • 11.10.3 Product and Service Introduction

    12 Data Source and Research Methodology

    The List of Tables and Figures (Totals 91 Figures and 178 Tables)

    • Figure Product Picture

    • Figure CAR T-Cell Therapy Market Size and Growth Rate of Allogeneic from 2014 to 2026

    • Figure CAR T-Cell Therapy Market Size and Growth Rate of Autologous from 2014 to 2026

    • Figure Market Share by Type in 2014

    • Figure Market Share by Type in 2018

    • Figure Market Share by Type in 2026

    • Figure Global CAR T-Cell Therapy Market Size and Growth Rate of Hospitals from 2014 to 2026

    • Figure Global CAR T-Cell Therapy Market Size and Growth Rate of Cancer Research Centers from 2014 to 2026

    • Figure Global CAR T-Cell Therapy Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Market Share by End-User in 2014

    • Figure Market Share by End-User in 2018

    • Figure Market Share by End-User in 2026

    • Figure North America CAR T-Cell Therapy Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure United States CAR T-Cell Therapy Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Canada CAR T-Cell Therapy Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico CAR T-Cell Therapy Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Europe CAR T-Cell Therapy Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Germany CAR T-Cell Therapy Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure UK CAR T-Cell Therapy Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure France CAR T-Cell Therapy Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Italy CAR T-Cell Therapy Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries CAR T-Cell Therapy Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Spain CAR T-Cell Therapy Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium CAR T-Cell Therapy Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Poland CAR T-Cell Therapy Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Russia CAR T-Cell Therapy Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey CAR T-Cell Therapy Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Asia-Pacific CAR T-Cell Therapy Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure China CAR T-Cell Therapy Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Japan CAR T-Cell Therapy Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Australia and New Zealand CAR T-Cell Therapy Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure India CAR T-Cell Therapy Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure ASEAN Countries CAR T-Cell Therapy Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure South Korea CAR T-Cell Therapy Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Latin America, Middle East & Africa CAR T-Cell Therapy Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure GCC Countries CAR T-Cell Therapy Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Brazil CAR T-Cell Therapy Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Nigeria CAR T-Cell Therapy Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure South Africa CAR T-Cell Therapy Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Argentina CAR T-Cell Therapy Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of CAR T-Cell Therapy Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2018

    • Figure Market Share of TOP 5 Players in 2018

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of CAR T-Cell Therapy

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of CAR T-Cell Therapy by Different Types from 2014 to 2026

    • Table Consumption Share of CAR T-Cell Therapy by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Allogeneic

    • Figure Market Size and Growth Rate of Autologous

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of CAR T-Cell Therapy by Different End-Users from 2014 to 2026

    • Table Consumption Share of CAR T-Cell Therapy by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Hospitals

    • Figure Market Size and Growth Rate of Cancer Research Centers

    • Figure Market Size and Growth Rate of Others

    • Table Global CAR T-Cell Therapy Production by Major Regions

    • Table Global CAR T-Cell Therapy Production Share by Major Regions

    • Figure Global CAR T-Cell Therapy Production Share by Major Regions in 2014

    • Figure Global CAR T-Cell Therapy Production Share by Major Regions in 2018

    • Figure Global CAR T-Cell Therapy Production Share by Major Regions in 2026

    • Table Global CAR T-Cell Therapy Consumption by Major Regions

    • Table Global CAR T-Cell Therapy Consumption Share by Major Regions

    • Figure Global CAR T-Cell Therapy Consumption Share by Major Regions in 2014

    • Figure Global CAR T-Cell Therapy Consumption Share by Major Regions in 2018

    • Figure Global CAR T-Cell Therapy Consumption Share by Major Regions in 2026

    • Table North America CAR T-Cell Therapy Production, Import, Consumption and Export Analysis

    • Table Europe CAR T-Cell Therapy Production, Import, Consumption and Export Analysis

    • Table Asia Pacific CAR T-Cell Therapy Production, Import, Consumption and Export Analysis

    • Table Latin America, Middle East & Africa CAR T-Cell Therapy Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in CAR T-Cell Therapy market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in CAR T-Cell Therapy market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in CAR T-Cell Therapy market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in CAR T-Cell Therapy market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table North America CAR T-Cell Therapy Consumption by Types from 2014 to 2026

    • Table North America CAR T-Cell Therapy Consumption Share by Types from 2014 to 2026

    • Figure North America CAR T-Cell Therapy Consumption Share by Types in 2014

    • Figure North America CAR T-Cell Therapy Consumption Share by Types in 2018

    • Figure North America CAR T-Cell Therapy Consumption Share by Types in 2026

    • Table North America CAR T-Cell Therapy Consumption by End-Users from 2014 to 2026

    • Table North America CAR T-Cell Therapy Consumption Share by End-Users from 2014 to 2026

    • Figure North America CAR T-Cell Therapy Consumption Share by End-Users in 2014

    • Figure North America CAR T-Cell Therapy Consumption Share by End-Users in 2018

    • Figure North America CAR T-Cell Therapy Consumption Share by End-Users in 2026

    • Table North America CAR T-Cell Therapy Consumption by Major Countries from 2014 to 2026

    • Table North America CAR T-Cell Therapy Consumption Share by Major Countries from 2014 to 2026

    • Figure North America CAR T-Cell Therapy Consumption Share by Major Countries in 2014

    • Figure North America CAR T-Cell Therapy Consumption Share by Major Countries in 2018

    • Figure North America CAR T-Cell Therapy Consumption Share by Major Countries in 2026

    • Figure United States CAR T-Cell Therapy Market Volume and Growth Rate from 2014 to 2026

    • Figure Canada CAR T-Cell Therapy Market Volume and Growth Rate from 2014 to 2026

    • Figure Mexico CAR T-Cell Therapy Market Volume and Growth Rate from 2014 to 2026

    • Table Europe CAR T-Cell Therapy Consumption by Types from 2014 to 2026

    • Table Europe CAR T-Cell Therapy Consumption Share by Types from 2014 to 2026

    • Figure Europe CAR T-Cell Therapy Consumption Share by Types in 2014

    • Figure Europe CAR T-Cell Therapy Consumption Share by Types in 2018

    • Figure Europe CAR T-Cell Therapy Consumption Share by Types in 2026

    • Table Europe CAR T-Cell Therapy Consumption by End-Users from 2014 to 2026

    • Table Europe CAR T-Cell Therapy Consumption Share by End-Users from 2014 to 2026

    • Figure Europe CAR T-Cell Therapy Consumption Share by End-Users in 2014

    • Figure Europe CAR T-Cell Therapy Consumption Share by End-Users in 2018

    • Figure Europe CAR T-Cell Therapy Consumption Share by End-Users in 2026

    • Table Europe CAR T-Cell Therapy Consumption by Major Countries from 2014 to 2026

    • Table Europe CAR T-Cell Therapy Consumption Share by Major Countries from 2014 to 2026

    • Figure Europe CAR T-Cell Therapy Consumption Share by Major Countries in 2014

    • Figure Europe CAR T-Cell Therapy Consumption Share by Major Countries in 2018

    • Figure Europe CAR T-Cell Therapy Consumption Share by Major Countries in 2026

    • Figure Germany CAR T-Cell Therapy Market Volume and Growth Rate from 2014 to 2026

    • Figure UK CAR T-Cell Therapy Market Volume and Growth Rate from 2014 to 2026

    • Figure France CAR T-Cell Therapy Market Volume and Growth Rate from 2014 to 2026

    • Figure Italy CAR T-Cell Therapy Market Volume and Growth Rate from 2014 to 2026

    • Figure Nordic Countries CAR T-Cell Therapy Market Volume and Growth Rate from 2014 to 2026

    • Figure Belgium CAR T-Cell Therapy Market Volume and Growth Rate from 2014 to 2026

    • Figure Poland CAR T-Cell Therapy Market Volume and Growth Rate from 2014 to 2026

    • Figure Russia CAR T-Cell Therapy Market Volume and Growth Rate from 2014 to 2026

    • Figure Turkey CAR T-Cell Therapy Market Volume and Growth Rate from 2014 to 2026

    • Table Asia Pacific CAR T-Cell Therapy Consumption by Types from 2014 to 2026

    • Table Asia Pacific CAR T-Cell Therapy Consumption Share by Types from 2014 to 2026

    • Figure Asia Pacific CAR T-Cell Therapy Consumption Share by Types in 2014

    • Figure Asia Pacific CAR T-Cell Therapy Consumption Share by Types in 2018

    • Figure Asia Pacific CAR T-Cell Therapy Consumption Share by Types in 2026

    • Table Asia Pacific CAR T-Cell Therapy Consumption by End-Users from 2014 to 2026

    • Table Asia Pacific CAR T-Cell Therapy Consumption Share by End-Users from 2014 to 2026

    • Figure Asia Pacific CAR T-Cell Therapy Consumption Share by End-Users in 2014

    • Figure Asia Pacific CAR T-Cell Therapy Consumption Share by End-Users in 2018

    • Figure Asia Pacific CAR T-Cell Therapy Consumption Share by End-Users in 2026

    • Table Asia Pacific CAR T-Cell Therapy Consumption by Major Countries from 2014 to 2026

    • Table Asia Pacific CAR T-Cell Therapy Consumption Share by Major Countries from 2014 to 2026

    • Figure Asia Pacific CAR T-Cell Therapy Consumption Share by Major Countries in 2014

    • Figure Asia Pacific CAR T-Cell Therapy Consumption Share by Major Countries in 2018

    • Figure Asia Pacific CAR T-Cell Therapy Consumption Share by Major Countries in 2026

    • Figure China CAR T-Cell Therapy Market Volume and Growth Rate from 2014 to 2026

    • Figure Japan CAR T-Cell Therapy Market Volume and Growth Rate from 2014 to 2026

    • Figure Australia and New ZealandCAR T-Cell Therapy Market Volume and Growth Rate from 2014 to 2026

    • Figure India CAR T-Cell Therapy Market Volume and Growth Rate from 2014 to 2026

    • Figure ASEAN Countries CAR T-Cell Therapy Market Volume and Growth Rate from 2014 to 2026

    • Figure South Korea CAR T-Cell Therapy Market Volume and Growth Rate from 2014 to 2026

    • Table Latin America, Middle East & Africa CAR T-Cell Therapy Consumption by Types from 2014 to 2026

    • Table Latin America, Middle East & Africa CAR T-Cell Therapy Consumption Share by Types from 2014 to 2026

    • Figure Latin America, Middle East & Africa CAR T-Cell Therapy Consumption Share by Types in 2014

    • Figure Latin America, Middle East & Africa CAR T-Cell Therapy Consumption Share by Types in 2018

    • Figure Latin America, Middle East & Africa CAR T-Cell Therapy Consumption Share by Types in 2026

    • Table Latin America, Middle East & Africa CAR T-Cell Therapy Consumption by End-Users from 2014 to 2026

    • Table Latin America, Middle East & Africa CAR T-Cell Therapy Consumption Share by End-Users from 2014 to 2026

    • Figure Latin America, Middle East & Africa CAR T-Cell Therapy Consumption Share by End-Users in 2014

    • Figure Latin America, Middle East & Africa CAR T-Cell Therapy Consumption Share by End-Users in 2018

    • Figure Latin America, Middle East & Africa CAR T-Cell Therapy Consumption Share by End-Users in 2026

    • Table Latin America, Middle East & Africa CAR T-Cell Therapy Consumption by Major Countries from 2014 to 2026

    • Table Latin America, Middle East & Africa CAR T-Cell Therapy Consumption Share by Major Countries from 2014 to 2026

    • Figure Latin America, Middle East & Africa CAR T-Cell Therapy Consumption Share by Major Countries in 2014

    • Figure Latin America, Middle East & Africa CAR T-Cell Therapy Consumption Share by Major Countries in 2018

    • Figure Latin America, Middle East & Africa CAR T-Cell Therapy Consumption Share by Major Countries in 2026

    • Figure GCC Countries CAR T-Cell Therapy Market Volume and Growth Rate from 2014 to 2026

    • Figure Brazil CAR T-Cell Therapy Market Volume and Growth Rate from 2014 to 2026

    • Figure Nigeria CAR T-Cell Therapy Market Volume and Growth Rate from 2014 to 2026

    • Figure South Africa CAR T-Cell Therapy Market Volume and Growth Rate from 2014 to 2026

    • Figure Argentina CAR T-Cell Therapy Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of Autolus Therapeutics PLC (UK)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Autolus Therapeutics PLC (UK)

    • Figure Sales and Growth Rate Analysis of Autolus Therapeutics PLC (UK)

    • Figure Revenue and Market Share Analysis of Autolus Therapeutics PLC (UK)

    • Table Product and Service Introduction of Autolus Therapeutics PLC (UK)

    • Table Company Profile and Development Status of Juno Therapeutics (US)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Juno Therapeutics (US)

    • Figure Sales and Growth Rate Analysis of Juno Therapeutics (US)

    • Figure Revenue and Market Share Analysis of Juno Therapeutics (US)

    • Table Product and Service Introduction of Juno Therapeutics (US)

    • Table Company Profile and Development Status of Cellectis (France)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Cellectis (France)

    • Figure Sales and Growth Rate Analysis of Cellectis (France)

    • Figure Revenue and Market Share Analysis of Cellectis (France)

    • Table Product and Service Introduction of Cellectis (France)

    • Table Company Profile and Development Status of Kite Pharma (US)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Kite Pharma (US)

    • Figure Sales and Growth Rate Analysis of Kite Pharma (US)

    • Figure Revenue and Market Share Analysis of Kite Pharma (US)

    • Table Product and Service Introduction of Kite Pharma (US)

    • Table Company Profile and Development Status of CARsgen Therapeutics (China)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of CARsgen Therapeutics (China)

    • Figure Sales and Growth Rate Analysis of CARsgen Therapeutics (China)

    • Figure Revenue and Market Share Analysis of CARsgen Therapeutics (China)

    • Table Product and Service Introduction of CARsgen Therapeutics (China)

    • Table Company Profile and Development Status of Novartis AG (Switzerland)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis AG (Switzerland)

    • Figure Sales and Growth Rate Analysis of Novartis AG (Switzerland)

    • Figure Revenue and Market Share Analysis of Novartis AG (Switzerland)

    • Table Product and Service Introduction of Novartis AG (Switzerland)

    • Table Company Profile and Development Status of Pfizer, Inc (US)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer, Inc (US)

    • Figure Sales and Growth Rate Analysis of Pfizer, Inc (US)

    • Figure Revenue and Market Share Analysis of Pfizer, Inc (US)

    • Table Product and Service Introduction of Pfizer, Inc (US)

    • Table Company Profile and Development Status of Sorrento Therapeutics (US)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sorrento Therapeutics (US)

    • Figure Sales and Growth Rate Analysis of Sorrento Therapeutics (US)

    • Figure Revenue and Market Share Analysis of Sorrento Therapeutics (US)

    • Table Product and Service Introduction of Sorrento Therapeutics (US)

    • Table Company Profile and Development Status of Mustang Bio (US)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mustang Bio (US)

    • Figure Sales and Growth Rate Analysis of Mustang Bio (US)

    • Figure Revenue and Market Share Analysis of Mustang Bio (US)

    • Table Product and Service Introduction of Mustang Bio (US)

    • Table Company Profile and Development Status of Legend Biotech (US)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Legend Biotech (US)

    • Figure Sales and Growth Rate Analysis of Legend Biotech (US)

    • Figure Revenue and Market Share Analysis of Legend Biotech (US)

    • Table Product and Service Introduction of Legend Biotech (US)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.